Price Alert

Praxis Precision Medicine... (PRAX)

NASDAQ: PRAX · Real-Time Price · USD

54.38

-0.81 (-1.47%)

At close: Oct 03, 2025, 3:59 PM

54.38

0.00%

After-hours: Oct 03, 2025, 04:20 PM EDT

-1.47% (1D)

Bid	45
Market Cap	1.14B
Revenue (ttm)	7.76M
Net Income (ttm)	-251.01M
EPS (ttm)	-12.4
PE Ratio (ttm)	-4.39
Forward PE	-4.4
Analyst	Buy
Dividends	n/a

Ask	62
Volume	260,285
Avg. Volume (20D)	504,022.5
Open	55.78
Previous Close	55.19
Day's Range	53.31 - 55.86
52-Week Range	26.70 - 91.83
Beta	2.64
Ex-Dividend Date	n/a

About PRAX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PRAX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Praxis Precision Medicines Inc. is scheduled to release its earnings on Nov 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-5.55%

Praxis Precision Medicines shares are trading lowe... Unlock content with Pro Subscription

7 months ago

-13.08%

Praxis Precision Mediciines shares are trading lower after multiple firms cut their respective price targets on the stock.

News

6 days ago · businesswire.com

ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provides Corporate Update

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, tod...

1 month ago · businesswire.com

PRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)---- $PRAX--PRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. Fraud Investigation with the Schall Law Firm.

2 months ago · seekingalpha.com

Praxis Precision Medicines, Inc. (PRAX) Q2 2025 Earnings Call Transcript

Praxis Precision Medicines, Inc. (NASDAQ:PRAX ) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants a - Corporate Participant Marcio Silva De'Souza - President, CEO & Direc...

2 months ago · fool.com

Praxis (PRAX) Q2 Loss Widens 90%